Concepedia

Mary Jo Staruch

MJ

30

Publications

3.2K

Citations

23

H-Index

1981

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Harvard University

Mary Jo Staruch is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and inflammation.

Top concepts

Publications per year

1981–2004

30

Publications

30

Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

Francis J. Dumont, Mary Jo Staruch, Sam L. Koprak et al. · The Journal of Immunology · 1990 · 607 citations

The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.

Francis J. Dumont, Michael Melino, Mary Jo Staruch et al. · The Journal of Immunology · 1990 · 355 citations · Full text

The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.

Francis J. Dumont, Mary Jo Staruch, Sam L. Koprak et al. · The Journal of Experimental Medicine · 1992 · 253 citations · Full text

, , +19

Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?

N H Sigal, Francis J. Dumont, P. L. DURETTE et al. · The Journal of Experimental Medicine · 1991 · 249 citations · Full text

, , +18

Binding and Functional Properties of Recombinant and Endogenous CXCR3 Chemokine Receptors

Youmin Weng, Salvatore Siciliano, K E Waldburger et al. · Journal of Biological Chemistry · 1998 · 215 citations · Full text

Rows per page

1–5 of 30